White House, weight loss drugs
Digest more
The White House is in discussions with the makers of weight loss drugs Wegovy and Zepbound to drastically lower prices, NBC News has learned. The prices could drop from an average price of $1,300 a month to $150 a month,
TrumpRx will offer Novo Nordisk's Ozempic and Wegovy through TrumpRx for $350 and Eli Lilly and Company's Zepbound and orforglipron, if approved by the FDA, for $346.
Eli Lilly and Novo Nordisk will lower prices for GLP-1 drugs, aligning with new drug pricing initiatives and Medicare Part D pilot coverage starting April 2026. Lilly's Zepbound and orforglipron will be available at reduced prices,
A pharmaceutical executive fainted Thursday at the White House during President Donald Trump's announcement on weight loss drug costs, prompting immediate medical intervention from Dr. Mehmet Oz.
Everyday Health on MSN
White House Slashes GLP-1 Costs, Permits Medicare Coverage for Obesity
A deal with drugmakers also means that Medicare would cover obesity drugs for the first time. But certain limitations persist.
The agreement will also secure a $150 price for future weight loss pills from Novo Nordisk and Eli Lilly—at least initially.
A White House guest collapsed behind President Trump during an Oval Office press conference, leading to an abrupt pause in coverage. A spokesperson from Eli Lilly said the man experienced a 'medical situation.
Feedback